Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034067 (
emphysema
)
11,506
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The histological subtypes by peripheral tumor location remain uncharacterized in COPD patients with
emphysema
. We investigated histologic subtypes of peripheral lung cancers based on the context of heterogeneous
emphysema
distribution in patients with airflow limitation and CT-determined
emphysema
. A retrospective, cross-sectional study was conducted using data from 754 patients with airflow limitation and newly-diagnosed primary lung cancers from February 2013 to February 2015. Of these, 230 patients had
emphysema
, as determined by computed tomography software designed to quantify
emphysema
. Among the 230 patients, the most common subtype in central lesions (n=84) was squamous cell carcinoma (SCC) (n=64/84, 76%).
Adenocarcinoma
(
ADC
) was more frequently observed in peripheral lesions (n=146) than central lesions (58/146 [40%] vs. 4/84 [5%], p<0.001). In peripheral lesions,
ADC
was more frequently seen in areas without
emphysema
than
emphysema
areas (43/74 [58%] vs. 15/72 [21%], p<0.001), while SCC was more frequently found in
emphysema
areas than areas without
emphysema
(44/72 [61%] vs. 13/74 [18%], p<0.001). These associations persisted with adjustments for age, sex, smoking status and forced expiratory volume in 1s. In patients with both airflow limitation and CT-determined
emphysema
, the main histological subtype of peripheral lung cancer was SCC in
emphysema
areas and
ADC
in areas without
emphysema
.
...
PMID:Different histological subtypes of peripheral lung cancer based on emphysema distribution in patients with both airflow limitation and CT-determined emphysema. 2821 91